Skip to main content

Precision medicine startup Syapse raises $30 million to expand cancer tech, S.F. workforce

Syapse is seeing fast growth as more health systems and providers look to create precision medicine programs and offer personalized treatment in cancer care. And as data and collaboration increase, providers may get closer to developing new cancer therapies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.